Global Osimertinib Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Osimertinib Industry Forecast” looks at past sales and reviews total world Osimertinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Osimertinib sales for 2023 through 2029. With Osimertinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osimertinib industry.
This Insight Report provides a comprehensive analysis of the global Osimertinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osimertinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Osimertinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osimertinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osimertinib.
The global Osimertinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Osimertinib players cover AstraZeneca, Incepta Pharmaceuticals Limited, Everest Pharmaceuticals, Beacon Pharma and Drug International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Osimertinib market?
What factors are driving Osimertinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Osimertinib market opportunities vary by end market size?
How does Osimertinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Osimertinib Industry Forecast” looks at past sales and reviews total world Osimertinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Osimertinib sales for 2023 through 2029. With Osimertinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osimertinib industry.
This Insight Report provides a comprehensive analysis of the global Osimertinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osimertinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Osimertinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osimertinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osimertinib.
The global Osimertinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Osimertinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Osimertinib players cover AstraZeneca, Incepta Pharmaceuticals Limited, Everest Pharmaceuticals, Beacon Pharma and Drug International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 40mg*30 Tablets
- 80mg*30 Tablets
- 40mg*10 Tablets
- 80mg*10 Tablets
- Locally Advanced NSCLC
- Metastatic NSCLC
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Incepta Pharmaceuticals Limited
- Everest Pharmaceuticals
- Beacon Pharma
- Drug International
What is the 10-year outlook for the global Osimertinib market?
What factors are driving Osimertinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Osimertinib market opportunities vary by end market size?
How does Osimertinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Osimertinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Osimertinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Osimertinib by Country/Region, 2018, 2022 & 2029
2.2 Osimertinib Segment by Type
2.2.1 40mg*30 Tablets
2.2.2 80mg*30 Tablets
2.2.3 40mg*10 Tablets
2.2.4 80mg*10 Tablets
2.3 Osimertinib Sales by Type
2.3.1 Global Osimertinib Sales Market Share by Type (2018-2023)
2.3.2 Global Osimertinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Osimertinib Sale Price by Type (2018-2023)
2.4 Osimertinib Segment by Application
2.4.1 Locally Advanced NSCLC
2.4.2 Metastatic NSCLC
2.4.3 Other
2.5 Osimertinib Sales by Application
2.5.1 Global Osimertinib Sale Market Share by Application (2018-2023)
2.5.2 Global Osimertinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Osimertinib Sale Price by Application (2018-2023)
3 GLOBAL OSIMERTINIB BY COMPANY
3.1 Global Osimertinib Breakdown Data by Company
3.1.1 Global Osimertinib Annual Sales by Company (2018-2023)
3.1.2 Global Osimertinib Sales Market Share by Company (2018-2023)
3.2 Global Osimertinib Annual Revenue by Company (2018-2023)
3.2.1 Global Osimertinib Revenue by Company (2018-2023)
3.2.2 Global Osimertinib Revenue Market Share by Company (2018-2023)
3.3 Global Osimertinib Sale Price by Company
3.4 Key Manufacturers Osimertinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osimertinib Product Location Distribution
3.4.2 Players Osimertinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION
4.1 World Historic Osimertinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Osimertinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Osimertinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Osimertinib Market Size by Country/Region (2018-2023)
4.2.1 Global Osimertinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Osimertinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Osimertinib Sales Growth
4.4 APAC Osimertinib Sales Growth
4.5 Europe Osimertinib Sales Growth
4.6 Middle East & Africa Osimertinib Sales Growth
5 AMERICAS
5.1 Americas Osimertinib Sales by Country
5.1.1 Americas Osimertinib Sales by Country (2018-2023)
5.1.2 Americas Osimertinib Revenue by Country (2018-2023)
5.2 Americas Osimertinib Sales by Type
5.3 Americas Osimertinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osimertinib Sales by Region
6.1.1 APAC Osimertinib Sales by Region (2018-2023)
6.1.2 APAC Osimertinib Revenue by Region (2018-2023)
6.2 APAC Osimertinib Sales by Type
6.3 APAC Osimertinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Osimertinib by Country
7.1.1 Europe Osimertinib Sales by Country (2018-2023)
7.1.2 Europe Osimertinib Revenue by Country (2018-2023)
7.2 Europe Osimertinib Sales by Type
7.3 Europe Osimertinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Osimertinib by Country
8.1.1 Middle East & Africa Osimertinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Osimertinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Osimertinib Sales by Type
8.3 Middle East & Africa Osimertinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osimertinib
10.3 Manufacturing Process Analysis of Osimertinib
10.4 Industry Chain Structure of Osimertinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Osimertinib Distributors
11.3 Osimertinib Customer
12 WORLD FORECAST REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION
12.1 Global Osimertinib Market Size Forecast by Region
12.1.1 Global Osimertinib Forecast by Region (2024-2029)
12.1.2 Global Osimertinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Osimertinib Forecast by Type
12.7 Global Osimertinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Osimertinib Product Portfolios and Specifications
13.1.3 AstraZeneca Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Incepta Pharmaceuticals Limited
13.2.1 Incepta Pharmaceuticals Limited Company Information
13.2.2 Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
13.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Incepta Pharmaceuticals Limited Main Business Overview
13.2.5 Incepta Pharmaceuticals Limited Latest Developments
13.3 Everest Pharmaceuticals
13.3.1 Everest Pharmaceuticals Company Information
13.3.2 Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
13.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Everest Pharmaceuticals Main Business Overview
13.3.5 Everest Pharmaceuticals Latest Developments
13.4 Beacon Pharma
13.4.1 Beacon Pharma Company Information
13.4.2 Beacon Pharma Osimertinib Product Portfolios and Specifications
13.4.3 Beacon Pharma Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beacon Pharma Main Business Overview
13.4.5 Beacon Pharma Latest Developments
13.5 Drug International
13.5.1 Drug International Company Information
13.5.2 Drug International Osimertinib Product Portfolios and Specifications
13.5.3 Drug International Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Drug International Main Business Overview
13.5.5 Drug International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Osimertinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Osimertinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Osimertinib by Country/Region, 2018, 2022 & 2029
2.2 Osimertinib Segment by Type
2.2.1 40mg*30 Tablets
2.2.2 80mg*30 Tablets
2.2.3 40mg*10 Tablets
2.2.4 80mg*10 Tablets
2.3 Osimertinib Sales by Type
2.3.1 Global Osimertinib Sales Market Share by Type (2018-2023)
2.3.2 Global Osimertinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Osimertinib Sale Price by Type (2018-2023)
2.4 Osimertinib Segment by Application
2.4.1 Locally Advanced NSCLC
2.4.2 Metastatic NSCLC
2.4.3 Other
2.5 Osimertinib Sales by Application
2.5.1 Global Osimertinib Sale Market Share by Application (2018-2023)
2.5.2 Global Osimertinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Osimertinib Sale Price by Application (2018-2023)
3 GLOBAL OSIMERTINIB BY COMPANY
3.1 Global Osimertinib Breakdown Data by Company
3.1.1 Global Osimertinib Annual Sales by Company (2018-2023)
3.1.2 Global Osimertinib Sales Market Share by Company (2018-2023)
3.2 Global Osimertinib Annual Revenue by Company (2018-2023)
3.2.1 Global Osimertinib Revenue by Company (2018-2023)
3.2.2 Global Osimertinib Revenue Market Share by Company (2018-2023)
3.3 Global Osimertinib Sale Price by Company
3.4 Key Manufacturers Osimertinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osimertinib Product Location Distribution
3.4.2 Players Osimertinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION
4.1 World Historic Osimertinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Osimertinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Osimertinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Osimertinib Market Size by Country/Region (2018-2023)
4.2.1 Global Osimertinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Osimertinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Osimertinib Sales Growth
4.4 APAC Osimertinib Sales Growth
4.5 Europe Osimertinib Sales Growth
4.6 Middle East & Africa Osimertinib Sales Growth
5 AMERICAS
5.1 Americas Osimertinib Sales by Country
5.1.1 Americas Osimertinib Sales by Country (2018-2023)
5.1.2 Americas Osimertinib Revenue by Country (2018-2023)
5.2 Americas Osimertinib Sales by Type
5.3 Americas Osimertinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osimertinib Sales by Region
6.1.1 APAC Osimertinib Sales by Region (2018-2023)
6.1.2 APAC Osimertinib Revenue by Region (2018-2023)
6.2 APAC Osimertinib Sales by Type
6.3 APAC Osimertinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Osimertinib by Country
7.1.1 Europe Osimertinib Sales by Country (2018-2023)
7.1.2 Europe Osimertinib Revenue by Country (2018-2023)
7.2 Europe Osimertinib Sales by Type
7.3 Europe Osimertinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Osimertinib by Country
8.1.1 Middle East & Africa Osimertinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Osimertinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Osimertinib Sales by Type
8.3 Middle East & Africa Osimertinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osimertinib
10.3 Manufacturing Process Analysis of Osimertinib
10.4 Industry Chain Structure of Osimertinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Osimertinib Distributors
11.3 Osimertinib Customer
12 WORLD FORECAST REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION
12.1 Global Osimertinib Market Size Forecast by Region
12.1.1 Global Osimertinib Forecast by Region (2024-2029)
12.1.2 Global Osimertinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Osimertinib Forecast by Type
12.7 Global Osimertinib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Osimertinib Product Portfolios and Specifications
13.1.3 AstraZeneca Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Incepta Pharmaceuticals Limited
13.2.1 Incepta Pharmaceuticals Limited Company Information
13.2.2 Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
13.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Incepta Pharmaceuticals Limited Main Business Overview
13.2.5 Incepta Pharmaceuticals Limited Latest Developments
13.3 Everest Pharmaceuticals
13.3.1 Everest Pharmaceuticals Company Information
13.3.2 Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
13.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Everest Pharmaceuticals Main Business Overview
13.3.5 Everest Pharmaceuticals Latest Developments
13.4 Beacon Pharma
13.4.1 Beacon Pharma Company Information
13.4.2 Beacon Pharma Osimertinib Product Portfolios and Specifications
13.4.3 Beacon Pharma Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beacon Pharma Main Business Overview
13.4.5 Beacon Pharma Latest Developments
13.5 Drug International
13.5.1 Drug International Company Information
13.5.2 Drug International Osimertinib Product Portfolios and Specifications
13.5.3 Drug International Osimertinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Drug International Main Business Overview
13.5.5 Drug International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Osimertinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Osimertinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg*30 Tablets
Table 4. Major Players of 80mg*30 Tablets
Table 5. Major Players of 40mg*10 Tablets
Table 6. Major Players of 80mg*10 Tablets
Table 7. Global Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 8. Global Osimertinib Sales Market Share by Type (2018-2023)
Table 9. Global Osimertinib Revenue by Type (2018-2023) & ($ million)
Table 10. Global Osimertinib Revenue Market Share by Type (2018-2023)
Table 11. Global Osimertinib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 12. Global Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 13. Global Osimertinib Sales Market Share by Application (2018-2023)
Table 14. Global Osimertinib Revenue by Application (2018-2023)
Table 15. Global Osimertinib Revenue Market Share by Application (2018-2023)
Table 16. Global Osimertinib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 17. Global Osimertinib Sales by Company (2018-2023) & (K Pcs)
Table 18. Global Osimertinib Sales Market Share by Company (2018-2023)
Table 19. Global Osimertinib Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Osimertinib Revenue Market Share by Company (2018-2023)
Table 21. Global Osimertinib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 22. Key Manufacturers Osimertinib Producing Area Distribution and Sales Area
Table 23. Players Osimertinib Products Offered
Table 24. Osimertinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Osimertinib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 28. Global Osimertinib Sales Market Share Geographic Region (2018-2023)
Table 29. Global Osimertinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Osimertinib Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Osimertinib Sales by Country/Region (2018-2023) & (K Pcs)
Table 32. Global Osimertinib Sales Market Share by Country/Region (2018-2023)
Table 33. Global Osimertinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Osimertinib Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 36. Americas Osimertinib Sales Market Share by Country (2018-2023)
Table 37. Americas Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Osimertinib Revenue Market Share by Country (2018-2023)
Table 39. Americas Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 40. Americas Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 41. APAC Osimertinib Sales by Region (2018-2023) & (K Pcs)
Table 42. APAC Osimertinib Sales Market Share by Region (2018-2023)
Table 43. APAC Osimertinib Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Osimertinib Revenue Market Share by Region (2018-2023)
Table 45. APAC Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 46. APAC Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 47. Europe Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 48. Europe Osimertinib Sales Market Share by Country (2018-2023)
Table 49. Europe Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Osimertinib Revenue Market Share by Country (2018-2023)
Table 51. Europe Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 52. Europe Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Osimertinib Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Osimertinib Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Osimertinib
Table 60. Key Market Challenges & Risks of Osimertinib
Table 61. Key Industry Trends of Osimertinib
Table 62. Osimertinib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Osimertinib Distributors List
Table 65. Osimertinib Customer List
Table 66. Global Osimertinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 67. Global Osimertinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 69. Americas Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Osimertinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. APAC Osimertinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Europe Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 75. Middle East & Africa Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Osimertinib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 77. Global Osimertinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Osimertinib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 79. Global Osimertinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AstraZeneca Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca Osimertinib Product Portfolios and Specifications
Table 82. AstraZeneca Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Incepta Pharmaceuticals Limited Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 86. Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
Table 87. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Incepta Pharmaceuticals Limited Main Business
Table 89. Incepta Pharmaceuticals Limited Latest Developments
Table 90. Everest Pharmaceuticals Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 91. Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
Table 92. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Everest Pharmaceuticals Main Business
Table 94. Everest Pharmaceuticals Latest Developments
Table 95. Beacon Pharma Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 96. Beacon Pharma Osimertinib Product Portfolios and Specifications
Table 97. Beacon Pharma Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Beacon Pharma Main Business
Table 99. Beacon Pharma Latest Developments
Table 100. Drug International Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 101. Drug International Osimertinib Product Portfolios and Specifications
Table 102. Drug International Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Drug International Main Business
Table 104. Drug International Latest Developments
Table 1. Osimertinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Osimertinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg*30 Tablets
Table 4. Major Players of 80mg*30 Tablets
Table 5. Major Players of 40mg*10 Tablets
Table 6. Major Players of 80mg*10 Tablets
Table 7. Global Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 8. Global Osimertinib Sales Market Share by Type (2018-2023)
Table 9. Global Osimertinib Revenue by Type (2018-2023) & ($ million)
Table 10. Global Osimertinib Revenue Market Share by Type (2018-2023)
Table 11. Global Osimertinib Sale Price by Type (2018-2023) & (USD/Pcs)
Table 12. Global Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 13. Global Osimertinib Sales Market Share by Application (2018-2023)
Table 14. Global Osimertinib Revenue by Application (2018-2023)
Table 15. Global Osimertinib Revenue Market Share by Application (2018-2023)
Table 16. Global Osimertinib Sale Price by Application (2018-2023) & (USD/Pcs)
Table 17. Global Osimertinib Sales by Company (2018-2023) & (K Pcs)
Table 18. Global Osimertinib Sales Market Share by Company (2018-2023)
Table 19. Global Osimertinib Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Osimertinib Revenue Market Share by Company (2018-2023)
Table 21. Global Osimertinib Sale Price by Company (2018-2023) & (USD/Pcs)
Table 22. Key Manufacturers Osimertinib Producing Area Distribution and Sales Area
Table 23. Players Osimertinib Products Offered
Table 24. Osimertinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Osimertinib Sales by Geographic Region (2018-2023) & (K Pcs)
Table 28. Global Osimertinib Sales Market Share Geographic Region (2018-2023)
Table 29. Global Osimertinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Osimertinib Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Osimertinib Sales by Country/Region (2018-2023) & (K Pcs)
Table 32. Global Osimertinib Sales Market Share by Country/Region (2018-2023)
Table 33. Global Osimertinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Osimertinib Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 36. Americas Osimertinib Sales Market Share by Country (2018-2023)
Table 37. Americas Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Osimertinib Revenue Market Share by Country (2018-2023)
Table 39. Americas Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 40. Americas Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 41. APAC Osimertinib Sales by Region (2018-2023) & (K Pcs)
Table 42. APAC Osimertinib Sales Market Share by Region (2018-2023)
Table 43. APAC Osimertinib Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Osimertinib Revenue Market Share by Region (2018-2023)
Table 45. APAC Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 46. APAC Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 47. Europe Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 48. Europe Osimertinib Sales Market Share by Country (2018-2023)
Table 49. Europe Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Osimertinib Revenue Market Share by Country (2018-2023)
Table 51. Europe Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 52. Europe Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 53. Middle East & Africa Osimertinib Sales by Country (2018-2023) & (K Pcs)
Table 54. Middle East & Africa Osimertinib Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Osimertinib Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Osimertinib Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Osimertinib Sales by Type (2018-2023) & (K Pcs)
Table 58. Middle East & Africa Osimertinib Sales by Application (2018-2023) & (K Pcs)
Table 59. Key Market Drivers & Growth Opportunities of Osimertinib
Table 60. Key Market Challenges & Risks of Osimertinib
Table 61. Key Industry Trends of Osimertinib
Table 62. Osimertinib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Osimertinib Distributors List
Table 65. Osimertinib Customer List
Table 66. Global Osimertinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 67. Global Osimertinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 69. Americas Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Osimertinib Sales Forecast by Region (2024-2029) & (K Pcs)
Table 71. APAC Osimertinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Europe Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Osimertinib Sales Forecast by Country (2024-2029) & (K Pcs)
Table 75. Middle East & Africa Osimertinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Osimertinib Sales Forecast by Type (2024-2029) & (K Pcs)
Table 77. Global Osimertinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Osimertinib Sales Forecast by Application (2024-2029) & (K Pcs)
Table 79. Global Osimertinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. AstraZeneca Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca Osimertinib Product Portfolios and Specifications
Table 82. AstraZeneca Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Incepta Pharmaceuticals Limited Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 86. Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
Table 87. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Incepta Pharmaceuticals Limited Main Business
Table 89. Incepta Pharmaceuticals Limited Latest Developments
Table 90. Everest Pharmaceuticals Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 91. Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
Table 92. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Everest Pharmaceuticals Main Business
Table 94. Everest Pharmaceuticals Latest Developments
Table 95. Beacon Pharma Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 96. Beacon Pharma Osimertinib Product Portfolios and Specifications
Table 97. Beacon Pharma Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Beacon Pharma Main Business
Table 99. Beacon Pharma Latest Developments
Table 100. Drug International Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 101. Drug International Osimertinib Product Portfolios and Specifications
Table 102. Drug International Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Drug International Main Business
Table 104. Drug International Latest Developments
LIST OF FIGURES
Figure 1. Picture of Osimertinib
Figure 2. Osimertinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Osimertinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Osimertinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg*30 Tablets
Figure 10. Product Picture of 80mg*30 Tablets
Figure 11. Product Picture of 40mg*10 Tablets
Figure 12. Product Picture of 80mg*10 Tablets
Figure 13. Global Osimertinib Sales Market Share by Type in 2022
Figure 14. Global Osimertinib Revenue Market Share by Type (2018-2023)
Figure 15. Osimertinib Consumed in Locally Advanced NSCLC
Figure 16. Global Osimertinib Market: Locally Advanced NSCLC (2018-2023) & (K Pcs)
Figure 17. Osimertinib Consumed in Metastatic NSCLC
Figure 18. Global Osimertinib Market: Metastatic NSCLC (2018-2023) & (K Pcs)
Figure 19. Osimertinib Consumed in Other
Figure 20. Global Osimertinib Market: Other (2018-2023) & (K Pcs)
Figure 21. Global Osimertinib Sales Market Share by Application (2022)
Figure 22. Global Osimertinib Revenue Market Share by Application in 2022
Figure 23. Osimertinib Sales Market by Company in 2022 (K Pcs)
Figure 24. Global Osimertinib Sales Market Share by Company in 2022
Figure 25. Osimertinib Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Osimertinib Revenue Market Share by Company in 2022
Figure 27. Global Osimertinib Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Osimertinib Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Osimertinib Sales 2018-2023 (K Pcs)
Figure 30. Americas Osimertinib Revenue 2018-2023 ($ Millions)
Figure 31. APAC Osimertinib Sales 2018-2023 (K Pcs)
Figure 32. APAC Osimertinib Revenue 2018-2023 ($ Millions)
Figure 33. Europe Osimertinib Sales 2018-2023 (K Pcs)
Figure 34. Europe Osimertinib Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Osimertinib Sales 2018-2023 (K Pcs)
Figure 36. Middle East & Africa Osimertinib Revenue 2018-2023 ($ Millions)
Figure 37. Americas Osimertinib Sales Market Share by Country in 2022
Figure 38. Americas Osimertinib Revenue Market Share by Country in 2022
Figure 39. Americas Osimertinib Sales Market Share by Type (2018-2023)
Figure 40. Americas Osimertinib Sales Market Share by Application (2018-2023)
Figure 41. United States Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Osimertinib Sales Market Share by Region in 2022
Figure 46. APAC Osimertinib Revenue Market Share by Regions in 2022
Figure 47. APAC Osimertinib Sales Market Share by Type (2018-2023)
Figure 48. APAC Osimertinib Sales Market Share by Application (2018-2023)
Figure 49. China Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Osimertinib Sales Market Share by Country in 2022
Figure 57. Europe Osimertinib Revenue Market Share by Country in 2022
Figure 58. Europe Osimertinib Sales Market Share by Type (2018-2023)
Figure 59. Europe Osimertinib Sales Market Share by Application (2018-2023)
Figure 60. Germany Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Osimertinib Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Osimertinib Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Osimertinib Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Osimertinib Sales Market Share by Application (2018-2023)
Figure 69. Egypt Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Osimertinib in 2022
Figure 75. Manufacturing Process Analysis of Osimertinib
Figure 76. Industry Chain Structure of Osimertinib
Figure 77. Channels of Distribution
Figure 78. Global Osimertinib Sales Market Forecast by Region (2024-2029)
Figure 79. Global Osimertinib Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Osimertinib Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Osimertinib Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Osimertinib Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Osimertinib Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Osimertinib
Figure 2. Osimertinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Osimertinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Osimertinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg*30 Tablets
Figure 10. Product Picture of 80mg*30 Tablets
Figure 11. Product Picture of 40mg*10 Tablets
Figure 12. Product Picture of 80mg*10 Tablets
Figure 13. Global Osimertinib Sales Market Share by Type in 2022
Figure 14. Global Osimertinib Revenue Market Share by Type (2018-2023)
Figure 15. Osimertinib Consumed in Locally Advanced NSCLC
Figure 16. Global Osimertinib Market: Locally Advanced NSCLC (2018-2023) & (K Pcs)
Figure 17. Osimertinib Consumed in Metastatic NSCLC
Figure 18. Global Osimertinib Market: Metastatic NSCLC (2018-2023) & (K Pcs)
Figure 19. Osimertinib Consumed in Other
Figure 20. Global Osimertinib Market: Other (2018-2023) & (K Pcs)
Figure 21. Global Osimertinib Sales Market Share by Application (2022)
Figure 22. Global Osimertinib Revenue Market Share by Application in 2022
Figure 23. Osimertinib Sales Market by Company in 2022 (K Pcs)
Figure 24. Global Osimertinib Sales Market Share by Company in 2022
Figure 25. Osimertinib Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Osimertinib Revenue Market Share by Company in 2022
Figure 27. Global Osimertinib Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Osimertinib Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Osimertinib Sales 2018-2023 (K Pcs)
Figure 30. Americas Osimertinib Revenue 2018-2023 ($ Millions)
Figure 31. APAC Osimertinib Sales 2018-2023 (K Pcs)
Figure 32. APAC Osimertinib Revenue 2018-2023 ($ Millions)
Figure 33. Europe Osimertinib Sales 2018-2023 (K Pcs)
Figure 34. Europe Osimertinib Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Osimertinib Sales 2018-2023 (K Pcs)
Figure 36. Middle East & Africa Osimertinib Revenue 2018-2023 ($ Millions)
Figure 37. Americas Osimertinib Sales Market Share by Country in 2022
Figure 38. Americas Osimertinib Revenue Market Share by Country in 2022
Figure 39. Americas Osimertinib Sales Market Share by Type (2018-2023)
Figure 40. Americas Osimertinib Sales Market Share by Application (2018-2023)
Figure 41. United States Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Osimertinib Sales Market Share by Region in 2022
Figure 46. APAC Osimertinib Revenue Market Share by Regions in 2022
Figure 47. APAC Osimertinib Sales Market Share by Type (2018-2023)
Figure 48. APAC Osimertinib Sales Market Share by Application (2018-2023)
Figure 49. China Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Osimertinib Sales Market Share by Country in 2022
Figure 57. Europe Osimertinib Revenue Market Share by Country in 2022
Figure 58. Europe Osimertinib Sales Market Share by Type (2018-2023)
Figure 59. Europe Osimertinib Sales Market Share by Application (2018-2023)
Figure 60. Germany Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Osimertinib Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Osimertinib Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Osimertinib Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Osimertinib Sales Market Share by Application (2018-2023)
Figure 69. Egypt Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Osimertinib Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Osimertinib in 2022
Figure 75. Manufacturing Process Analysis of Osimertinib
Figure 76. Industry Chain Structure of Osimertinib
Figure 77. Channels of Distribution
Figure 78. Global Osimertinib Sales Market Forecast by Region (2024-2029)
Figure 79. Global Osimertinib Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Osimertinib Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Osimertinib Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Osimertinib Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Osimertinib Revenue Market Share Forecast by Application (2024-2029)
